猿猴免疫缺陷病毒大猩猩具有跨物种以及在人群中传播的能力

doi:10.19871/j.cnki.xfcrbzz.2023.03.001

摘要/Abstract

摘要： 目的西非大猩猩（Gorilla gorilla gorilla）是猿猴免疫缺陷病毒_大猩猩（SIVgor）的天然宿主。本研究旨在确定SIVgor能否传播给人类并在人体内复制。方法首先将25只6~8周的NOD/SCID IL-2Rγc^-/-小鼠通过尾静脉注射移植人造血干细胞入免疫缺陷小鼠中,构建有完整人造血系统的人源化小鼠。然后通过静脉（5只）、直肠（7只）和阴道（5只）三种途径将人源化小鼠暴露于9×10⁴TCIU的SIVgor,每2周检测人源化小鼠体内HIV的病毒载量和CD4⁺T淋巴细胞水平,评估三种暴露途径SIVgor的传播能力、体内复制能力以及对CD4⁺T淋巴细胞的杀伤力。结果静脉暴露后,SIVgor在人源化小鼠中高效复制,病毒载量达到与HIV感染的人类相当。直肠和阴道接种病毒也导致人源化小鼠感染SIVgor。尽管SIVgor在人源化小鼠体内高水平复制,但外周血中人CD4⁺T淋巴细胞水平在三种暴露途径导致的感染中仅略有下降。而三种暴露途径导致的感染对小鼠其他组织中人CD4⁺T淋巴细胞的影响则略有不同：阴道暴露使阴道中的CD4⁺T淋巴细胞明显下降,而对其他组织中的人CD4⁺T淋巴细胞无影响;静脉和直肠暴露对各组织中人CD4⁺T淋巴细胞水平的影响不大。结论 SIVgor能通过静脉、直肠和阴道途径感染人源化小鼠并在其内高效复制。黏膜相关淋巴组织中SIVgor对CD4⁺T淋巴细胞的选择性细胞毒性与人类HIV-1感染相似。由于人类仍可因狩猎暴露于SIVs,新的人畜共患病可能再次发生。因此,建立能评估当前和未来人畜共患病的模型系统至关重要。

关键词: 猿猴免疫缺陷病毒_大猩猩, 人类免疫缺陷病毒, CD4⁺T淋巴细胞, 人源化小鼠

Abstract: Objective Western gorillas (Gorilla gorilla gorilla) are the natural hosts of simian immunodeficiency virus_gorilla (SIVgor). The primary objective of our study is to determine whether SIVgor is capable of being transmitted to and replicating in humans. Method Human hematopoietic stem cells were transplanted into immune-deficient mice via tail veil dose to make the humanized mice reconstituted with a complete human hematopoietic system. Through determining HIV viral loads and CD4⁺T cell levels in humanized mice, the capacity of SIVgor to be transmitted after intravenous and mucosal exposure, to replicate in vivo and to kill CD4⁺T cells were evaluated. Result After intravenous exposure, SIVgor replicated very efficiently in humanized mice reaching viral loads comparable to HIV infected humans. In addition, humanized mice were susceptible to SIVgor infection after mucosal exposure. Both rectal and vaginal inoculation led to disseminated infection. However, despite high levels of virus replication these infections resulted in only a modest reduction in the levels of human CD4⁺T cells in the peripheral blood of humanized mice. However, effects of SIVgor infection on human CD4⁺T cells in other tissues except blood via three exposure routes were slightly different: CD4⁺T cells in the vagina decreased significantly after vaginal exposure while those in other tissues were preserved; after venous and rectal exposure human CD4⁺T cells in all the studied tissues were rarely affected. Conclusion SIVgor was able to infect humanized mice via both intravenous and mucosal routes and then replicate efficiently in the infected animals. Selective cytotoxicity for CD4⁺T cells in mucosal associated lymphoid tissues recapitulated HIV-1 infection of humans. Since humans are still exposed to SIVs from bushmeat, new zoonoses are likely to occur. Therefore, it is critical to establish model systems that can evaluate present and future dangers.

Key words: Simian immunodeficiency virus_gorillas, Human immunodeficiency virus, CD4⁺T cells, Humanized mice

中图分类号:

R511

邹薇, 邬小萍, 陈新萍, 刘梨, 邹世杰, John Foster, J. Victor Garcia. 猿猴免疫缺陷病毒_大猩猩具有跨物种以及在人群中传播的能力[J]. 新发传染病电子杂志, 2023, 8(3): 1-6.

Zou Wei, Wu Xiaoping, Chen Xinping, Liu Li, Zou Shijie, John Foster, J. Victor Garcia. SIVgor has the capacity of zoonotic transmission and subsequent spread between humans[J]. Electronic Journal of Emerging Infectious Diseases, 2023, 8(3): 1-6.

参考文献

[1] VAN HEUVERSWYN F, PEETERS M.The Origins of HIV and Implications for the Global Epidemic[J]. Curr Infect Dis Rep, 2007, 9(4):338-346.
[2] NEEL C, ETIENNE L, LI Y, et al.Molecular Epidemiology of Simian Immunodeficiency Virus Infection in Wild-living Gorillas[J].J Virol,2010,84(3):1464-1476.
[3] HO DD, BIENIASZ PD.HIV-1 at 25[J]. Cell, 2008, 133(4): 561-565.
[4] HEMELAAR J, ELANGOVAN R, YUN J, et al.Global and Regional Molecular Epidemiology of HIV-1, 1990-2015: a Systematic Review, Global Survey, and Trend Analysis[J].Lancet Infect dis, 2019, 19(2):143-155.
[5] VAN HEUVERSWYN F, LI Y, NEEL C, et al.Human Immunodeficiency Viruses: SIV Infection in Wild Gorillas[J]. Nature, 2006, 444(7116):164.
[6] VALLARI A, HOLZMAYER V, HARRIS B, et al.Confirmation of Putative HIV-1 Group P in Cameroon[J]. J Virol, 2011, 85(3):1403-1407.
[7] BUSH S, TEBIT DM.HIV-1 Group O Origin, Evolution, Pathogenesis and Treatment: Unraveling the Complexity of an Outlier 25 Years Later[J]. AIDS Rev, 2015, 17(3):147-158.
[8] MARTIN C, GRACIAS S, CHARPENTIER C, et al.HIV-1 Non-group M Phenotypic Susceptibility in vitro to Bictegravir and Cabotegravir[J]. J Antimicrob Chemother, 2021, 76(9): 2306-2309.
[9] TAKEHISA J, KRAUS MH, AYOUBA A, et al.Origin and Biology of Simian Immunodeficiency Virus in Wild-living Western Gorillas[J]. J Virol 2009, 83(4):1635-1648.
[10] D'ARC M, FURTADO C, SIQUEIRA JD, et al. Assessment of the Gorilla Gut Virome in Association with Natural Simian Immunodeficiency Virus Infection[J]. Retrovirology, 2018, 15(1):19.
[11] VILLABONA-ARENAS CJ, AYOUBA A, ESTEBAN A, et al.Noninvasive Western Lowland Gorilla's Health Monitoring: A Decade of Simian Immunodeficiency Virus Surveillance in Southern Cameroon[J]. Ecol Evol, 2018, 8(22):10698-10710.
[12] ZHANG Z, GU Q, DE MANUEL MONTERO M, et al. Stably Expressed APOBEC3H Forms a Barrier for Cross-species Transmission of Simian Immunodeficiency Virus of Chimpanzee to Humans[J]. PLoS Pathog, 2017, 13(12):e1006746.
[13] DENTON PW,ESTES JD,SUN Z, et al.Antiretroviral Pre-exposure Prophylaxis Prevents Vaginal Transmission of HIV-1 in Humanized BLT Mice[J]. PLoS Med, 2008, 5(1):e16.
[14] GILLGRASS A, WESSELS JM, YANG JX, et al.Advances in Humanized Mouse Models to Improve Understanding of HIV-1 Pathogenesis and Immune Responses[J]. Front Immunol, 2021, 11:617516.
[15] SUN Z, DENTON PW, ESTES JD, et al.Intrarectal Transmission, Systemic Infection and CD4+ T Cell Depletion in Humanized Mice Infected with HIV-1[J]. J Exp Med, 2007, 204(4):705-714.
[16] TERAHARA K, IWABUCHI R, TSUNETSUGU-YOKOTA Y.Perspectives on Non-BLT Humanized Mouse Models for Studying HIV Pathogenesis and Therapy[J]. Viruses, 2021, 13(5):776.
[17] ISHIKAWA F, YASUKAWA M, LYONS B, et al.Development of Functional Human Blood and Immune Systems in NOD/SCID/IL2 Receptor Gamma Chain(Null) Mice[J]. Blood, 2005, 106(5):1565-1573.
[18] MARODON G, DESJARDINS D,MERCEY L,et al.High Diversity of the Immune Repertoire in Humanized NOD.SCID.Gamma c-/- Mice[J].Eur J Immunol, 2009, 39(8):2136-2145.
[19] NIE C, SATO K, MISAWA N, et al.Selective Infection of CD4+ Effector Memory T Lymphocytes Leads to Preferential Depletion of Memory T Lymphocytes in R5 HIV-1-Infected Humanized NOD/SCID/IL-2R Gamma Null Mice[J]. Virology, 2009, 394(1):64-72.
[20] DENTON PW, KRISKO JF, POWELL DA, et al.Systemic Administration of Antiretrovirals Prior to Exposure Prevents Rectal and Intravenous HIV-1 Transmission in Humanized BLT Mice[J]. PloS One, 2010, 5(1):e8829.
[21] BBOSA N, KALEEBU P, SSEMWANGA D.HIV Subtype Diversity Worldwide[J]. Curr Opin HIV AIDS, 2019, 14(3):153-160.
[22] KORBER B, GASCHEN B, YUSIM K, et al.Evolutionary and Immunological Implications of Contemporary HIV-1 Variation[J]. Br Med Bull, 2001, 58:19-42.
[23] KEELE BF, VAN HEUVERSWYN F, LI Y, et al.Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1[J]. Science, 2006, 313(5786):523-526.
[24] PLANTIER JC, LEOZ M, DICKERSON JE, et al.A New Human Immunodeficiency Virus Derived from Gorillas[J].Nat Med, 2009, 15(8):871-872.
[25] SALAZAR-GONZALEZ JF, SALAZAR MG, KEELE BF, et al.Genetic Identity, Biological Phenotype and Evolutionary Pathways of Transmitted/Founder Viruses in Acute and Early HIV-1 Infection[J]. J Exp Med, 2009, 206(6):1273-1289.
[26] SHATTOCK RJ, MOORE JP.Inhibiting Sexual Transmission of HIV-1 Infection[J]. Nat Rev Microbiol, 2003, 1(1):25-34.
[27] KAZER SW, WALKER BD, SHALEK AK.Evolution and Diversity of Immune Responses during Acute HIV Infection[J].Immunity, 2020, 53(5):908-924.
[28] BEDNAR MM, HAUSER BM, PING LH, et al.R5 Macrophage-Tropic HIV-1 in the Male Genital Tract[J]. J Virol, 2015, 89(20):10688-10692.
[29] WATKINS RL, ZOU W, DENTON PW, et al.In vivo Analysis of Highly Conserved Nef Activities in HIV-1 Replication and Pathogenesis[J]. Retrovirology, 2013, 10:125.
[30] ZOU W, DENTON PW, WATKINS RL, et al.Nef Functions in BLT Mice to Enhance HIV-1 Replication and Deplete CD4+CD8+ Thymocytes[J]. Retrovirology, 2012, 9:44.
[31] ALESSSANDRI-GRADT E, DE OLIVEIRA F, LEOZ M, et al.HIV-1 Group P Infection: Towards a Dead-End Infection[J] AIDS, 2018, 32(10):1317-1322.
[32] LINDBOE CF, FROLAND SS, WEFRING KW, et al.Autopsy Findings in Three Family Members with a Presumably Acquired Immunodeficiency Syndrome of Unknown Etiology[J].Acta Pathol Microbiol Immunol Scand A, 1986, 94(2):117-123.

猿猴免疫缺陷病毒_大猩猩具有跨物种以及在人群中传播的能力

SIVgor has the capacity of zoonotic transmission and subsequent spread between humans

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	韦玉素, 董文逸, 谢志满, 韦黎娟. 艾滋病抗病毒治疗药物不良反应研究进展[J]. 新发传染病电子杂志, 2023, 8(3): 79-83.
[2]	杨红红, 曾琴, 吴玉珊, 刘倩, 李明俊, 刘敏, 苏世芳. 287例HIV感染/AIDS合并初治菌阴与菌阳肺结核的临床特点分析[J]. 新发传染病电子杂志, 2023, 8(2): 45-48.
[3]	卢亦波, 潘世荣, 李春华, 陆普选, 吕圣秀. 艾滋病合并细菌性肺炎的临床影像诊断与鉴别诊断[J]. 新发传染病电子杂志, 2022, 7(4): 99-104.
[4]	周明, 黄丽花, 龚世江, 黄葵. 抗病毒治疗失败的HIV感染/AIDS患者基因型耐药特征分析[J]. 新发传染病电子杂志, 2022, 7(3): 37-40.
[5]	罗杰棋, 周昀, 巢华, 云永兴, 王展, 鲍晓慧, 郭昂, 郑广平. MAGiC序列在HIV相关神经认知障碍诊断中的应用价值[J]. 新发传染病电子杂志, 2022, 7(3): 55-59.
[6]	钟明, 宋毅杰, 王宁, 蒋良双, 姚晓军. 719例HIV感染/AIDS合并恶性肿瘤的流行病学特征分析[J]. 新发传染病电子杂志, 2022, 7(3): 60-63.
[7]	葛翠翠, 尹亚童, 江敏, 袁丽. 2017–2021年青岛市预防艾滋病、梅毒和乙型病毒性肝炎母婴传播动态观察效果分析[J]. 新发传染病电子杂志, 2022, 7(3): 64-67.
[8]	何丁玲, 赵霞, 郭利华. HIV感染/AIDS患者焦虑和抑郁的研究进展[J]. 新发传染病电子杂志, 2022, 7(3): 84-89.
[9]	中国性病艾滋病防治协会HIV合并结核病专业委员会. 人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识[J]. 新发传染病电子杂志, 2022, 7(1): 73-87.
[10]	冯文霞, 董常峰, 冯程, 姜楠, 黄佳, 赵宁波. 超声在HIV感染合并乙型病毒性肝炎肝硬化患者肝移植中的应用[J]. 新发传染病电子杂志, 2021, 6(4): 294-297.
[11]	刘鑫, 陈永宏, 陈瑞华, 田冰, 赵春娥. 重庆万州地区男男性行为人群HIV感染情况及其危险因素分析[J]. 新发传染病电子杂志, 2021, 6(4): 343-347.
[12]	任荣, 程晰, 刘荣荣, 袁功玲, 刘静, 姚文妍, 李敏. 艾滋病合并粟粒性肺结核的CT影像与CD4⁺T淋巴细胞低下程度的相关分析[J]. 新发传染病电子杂志, 2021, 6(3): 242-246.
[13]	杨钟平, 秦圆圆, 周怡宏, 陈耀凯. 新型冠状病毒肺炎合并HIV感染的临床特征及预后的系统文献分析[J]. 新发传染病电子杂志, 2021, 6(2): 113-118.
[14]	刘敏, 曾琴, 潘亮, 张辉芬, 霍琴, 陈耀凯. 聚乙二醇干扰素α-2b联合利巴韦林治疗HIV/HCV合并感染的回顾性研究[J]. 新发传染病电子杂志, 2021, 6(1): 31-34.
[15]	蒙志好, 覃善芳, 刘爱梅, 沈银忠. 含多替拉韦方案治疗人类免疫缺陷病毒急性感染1例并文献复习[J]. 新发传染病电子杂志, 2020, 5(3): 195-197.